Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
dfwl28's Profile
Displaying 201-250 of 816 result(s).
CYDY CytoDyn Inc
12/06/2023 2:14:50 PM
CCR5 in urothelial cancer Excerpt: (19)
CYDY CytoDyn Inc
12/05/2023 1:55:44 PM
OT: States criticize the slow FDA. (7)
CYDY CytoDyn Inc
12/05/2023 5:21:06 AM
OT: Therapy/research breakthrough f (5)
CYDY CytoDyn Inc
12/02/2023 10:53:26 AM
https://register.gotowebinar.com/r (19)
CYDY CytoDyn Inc
12/01/2023 6:52:07 PM
The first outside voice we will hea (3)
CYDY CytoDyn Inc
12/01/2023 10:21:42 AM
Abstract from article: https://www. (7)
CYDY CytoDyn Inc
11/27/2023 7:33:24 PM
The infamous CYDY - CCR5 gene. Neve (5)
CYDY CytoDyn Inc
11/21/2023 8:49:54 AM
CYDY now has a BELIEVER at the helm (7)
CYDY CytoDyn Inc
10/29/2023 8:13:06 AM
".I'm thinking about All of the glo (3)
CYDY CytoDyn Inc
10/28/2023 9:06:45 AM
New CCR 5 Study CCR5 promotes the (7)
CYDY CytoDyn Inc
10/27/2023 9:59:29 AM
"Dave Welch: this guy has very ecle (7)
CYDY CytoDyn Inc
10/25/2023 9:27:13 AM
Alzheimer OT? https://www.washingto (1)
CYDY CytoDyn Inc
09/28/2023 10:11:39 AM
I'm just thinking, at the time that (2)
CYDY CytoDyn Inc
09/22/2023 10:07:13 AM
OT Alz and lecanemab The drug seems (1)
CYDY CytoDyn Inc
09/13/2023 9:47:36 AM
bstract The G-protein-coupled recep (1)
CYDY CytoDyn Inc
09/05/2023 7:50:12 PM
https://neurosciencenews.com/ferro (4)
CYDY CytoDyn Inc
08/31/2023 11:17:00 AM
Mini-Review Article Monoclonal CCR5 (6)
CYDY CytoDyn Inc
08/31/2023 10:07:01 AM
Monoclonal CCR5 Antibody: A Promisi (9)
CYDY CytoDyn Inc
08/24/2023 10:36:40 AM
CCR5 Is a Therapeutic Target for R (8)
CYDY CytoDyn Inc
08/23/2023 6:42:37 PM
https://www.uclahealth.org/news/uc (13)
CYDY CytoDyn Inc
08/23/2023 11:23:34 AM
https://www.youtube.com/watch?v=lU (5)
CYDY CytoDyn Inc
08/14/2023 6:37:04 PM
My crude understanding of cancer an (4)
CYDY CytoDyn Inc
08/09/2023 12:39:35 PM
Evil Rabbit: "Or else how could the (3)
CYDY CytoDyn Inc
08/08/2023 10:18:40 AM
Doesn't say much for AI.
CYDY CytoDyn Inc
08/07/2023 8:48:53 AM
Sean: "Results published in HIV Cli
CYDY CytoDyn Inc
08/01/2023 10:51:19 AM
Oclavia Label Warning: Worsening of (3)
CYDY CytoDyn Inc
07/28/2023 3:27:50 PM
First guess - one of the Board memb (1)
CYDY CytoDyn Inc
07/26/2023 12:07:14 PM
Craig: "So basically, there really (4)
CYDY CytoDyn Inc
07/25/2023 5:22:38 PM
Jake: "I was elated when management (4)
CYDY CytoDyn Inc
07/25/2023 10:26:38 AM
NONE AFAIK. Jurisdiction? Authority
CYDY CytoDyn Inc
07/25/2023 9:26:29 AM
Every AI company in the world is lo (7)
CYDY CytoDyn Inc
07/23/2023 1:17:25 PM
MGK: "If the NDA permits, the Top L (1)
CYDY CytoDyn Inc
07/22/2023 9:39:48 AM
Don't believe in drug company consp (5)
CYDY CytoDyn Inc
07/18/2023 8:45:06 AM
Ohm's on the mark analysis. "Cytody (3)
CYDY CytoDyn Inc
07/15/2023 1:04:47 PM
The awesome upside of AI - mind bog (4)
CYDY CytoDyn Inc
07/10/2023 10:51:24 AM
Excerpt: "CCR5 may have the potenti (5)
CYDY CytoDyn Inc
07/07/2023 7:06:56 PM
CRISPR: extra chromosones and canc (1)
CYDY CytoDyn Inc
07/02/2023 6:13:08 PM
Ozempic brings to mind LL. Born to (1)
CYDY CytoDyn Inc
06/30/2023 7:39:26 PM
Cell proteins at work - tracked - a (4)
CYDY CytoDyn Inc
06/27/2023 10:25:36 AM
Excerpt: The levels of CCR5 and its (4)
CYDY CytoDyn Inc
06/26/2023 4:15:50 PM
Sorry, You are asking the wrong guy
CYDY CytoDyn Inc
06/25/2023 5:51:47 PM
Excerpt: "CCR5 and CCL5 are import (4)
CYDY CytoDyn Inc
06/23/2023 11:14:12 AM
Excerpt: In this study, we identif (3)
CYDY CytoDyn Inc
06/23/2023 10:01:25 AM
One ecerpt: "In essence, this work (1)
CYDY CytoDyn Inc
06/22/2023 11:00:23 AM
The best and only way to get a time
CYDY CytoDyn Inc
06/18/2023 4:58:59 PM
A new study reveals that the SARS-C (2)
CYDY CytoDyn Inc
06/12/2023 4:49:18 PM
Encouraging news: elsewhere in medi (1)
CYDY CytoDyn Inc
06/11/2023 6:59:16 PM
Covid can cause fusing of brain cel (3)
CYDY CytoDyn Inc
06/11/2023 4:57:57 PM
Dictionary Definitions from Oxford
CYDY CytoDyn Inc
06/06/2023 10:23:29 AM
SEARCH RESULTS FOR: CYTODYN @ DELVI (5)
Go to page:
  • << First
  • < Previous
  • 4
  • 5
  • Next >

Recent Articles

  • Knight Therapeutics' Innovative Relaunch of MYFEMBREE in Canada
  • Bread Financial's Upcoming Q3 2025 Earnings Call Details
  • Lula and Trump Discuss Trade Tariffs to Boost Collaboration
  • Midland Exploration Advances Jouvex Gold Project in Quebec
  • Crypto Market Update: Bitcoin Maintains Momentum Amidst Fluctuations
  • Exxon Mobil Highlights Potential Earnings Boost from Oil Prices
  • Arq Inc Prepares for Upcoming Third Quarter Earnings Call
  • Bread Financial to Announce Q3 2025 Earnings on October 23
  • UNITSĀ® Expands Reach: Recognized in Franchise Times Top 400
  • Essential Fire Safety Strategies from Pye-Barker Fire & Safety
  • 1911 Gold Unveils Promising Drilling Results at True North
  • Soligenix Reports Safety Progress in HyBryte Clinical Trial
  • Revolutionizing Marketing Compliance with AllocateRite's AI Tool
  • Boardwalk REIT Shows Stability and Growth in Recent Update
  • Strategic Partnership: JK Concepts, Inc. Joins Forces with JEB Capital
  • MAXKARE and MARNUR Launch Exciting October Wellness Deals
  • Innovative Study Unveils Potential Cannabis Addiction Solution
  • Allied Properties Gains Momentum in Office Leasing Market
  • KITS Eyecare Celebrates Impressive Q3 Revenue Growth Report
  • Join SelectQuote Investor Class Action with Schall Law Firm
  • Innovative Start-Up Competition at Alibaba.com's CoCreate Europe
  • Yann Goarin Leads Innovative AI Ventures at AAXIS
  • Coave Therapeutics Showcases Innovative Capsid Technology at ESGCT
  • Highlighting WaterPower Canada's Achievements in Clean Energy
  • Dataiku Unveils Agent Hub to Enhance AI Collaboration
  • Power Trading Unveils Innovative Trading Solutions for Asia
  • Feedzai's Innovative Approach Secures Leadership Position
  • Sound Group Finalizes Share Repurchase Program Successfully
  • Sagimet Biosciences Set to Showcase Fibrosis Findings at AASLD
  • Shoals Technologies Group, Inc. Upcoming Earnings Release
  • Ocular Therapeutix Innovation Highlighted at Scientific Conferences
  • Axsome Therapeutics Financial Update: Conference Call on Q3 2025
  • Insight into USA Rare Earth's Upcoming Financial Conference Call
  • Sono-Tek Corporation to Host Earnings Call on Financial Results
  • Akero Therapeutics Unveils Promising Efruxifermin Data for Liver Disease
  • Akero Therapeutics Showcases Efruxifermin Data at AASLD 2025
  • Aduro Clean Technologies Announces Conference Participation in 2025
  • Fractyl Health's Innovative Gene Therapy Shows Weight Loss Promise
  • Aduro Clean Technologies Debuts at Investment Conference
  • Anfield Energy's Velvet-Wood Mine Project Gains Momentum
  • Ocular Therapeutix Highlights Upcoming Scientific Engagements
  • Rekor Systems Partners with Georgia DOT for Major Contract
  • Caliber Properties Advances EV Charging Infrastructure Growth
  • Balchem Corporation to Host Q3 2025 Financial Results Call
  • Shoals Technologies Group Set for Q3 2025 Earnings Call
  • Sono-Tek Prepares for Earnings Call: Insights and Innovations
  • Sagimet Biosciences to Present Key Findings at AASLD 2025
  • GXO Strengthens Global Logistics Partnership with Dolce&Gabbana
  • Balchem Corporation Prepares for Q3 2025 Financial Review
  • Axsome Therapeutics Set to Share Q3 2025 Financial Insights
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site